
Pamela Rodriguez
Examiner (ID: 16616, Phone: (571)272-7122 , Office: P/3657 )
| Most Active Art Unit | 3657 |
| Art Unit(s) | 3613, 3683, 3642, 3657, 3103, 3616 |
| Total Applications | 1957 |
| Issued Applications | 1629 |
| Pending Applications | 123 |
| Abandoned Applications | 230 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5967295
[patent_doc_number] => 20020090343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Expanded perborate salt, use, and method of production'
[patent_app_type] => new
[patent_app_number] => 09/932766
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5477
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090343.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932766
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932766 | Expanded perborate salt, use, and method of production | Aug 16, 2001 | Issued |
Array
(
[id] => 1413726
[patent_doc_number] => 06514518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-04
[patent_title] => 'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof'
[patent_app_type] => B2
[patent_app_number] => 09/932245
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514518.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932245
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932245 | Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof | Aug 16, 2001 | Issued |
Array
(
[id] => 6688012
[patent_doc_number] => 20030031737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Medicinal composition and method of using it'
[patent_app_type] => new
[patent_app_number] => 09/923090
[patent_app_country] => US
[patent_app_date] => 2001-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923090
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923090 | Medicinal composition and method of using it | Aug 5, 2001 | Issued |
Array
(
[id] => 5999356
[patent_doc_number] => 20020028239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Tablet composition'
[patent_app_type] => new
[patent_app_number] => 09/920830
[patent_app_country] => US
[patent_app_date] => 2001-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3457
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028239.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920830
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920830 | Tablet composition | Aug 2, 2001 | Issued |
Array
(
[id] => 1406802
[patent_doc_number] => 06524611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-25
[patent_title] => 'Compositions containing creatine and creatinine'
[patent_app_type] => B2
[patent_app_number] => 09/917634
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9436
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09917634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/917634 | Compositions containing creatine and creatinine | Jul 30, 2001 | Issued |
Array
(
[id] => 6687983
[patent_doc_number] => 20030031708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'SYNERGISTIC FILLER COMPOSITION'
[patent_app_type] => new
[patent_app_number] => 09/915057
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1020
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031708.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915057
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915057 | Synergistic filler composition | Jul 24, 2001 | Issued |
| 09/857795 | Medicinal compositions for oral use | Jul 18, 2001 | Abandoned |
Array
(
[id] => 1316588
[patent_doc_number] => 06605302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-12
[patent_title] => 'Drug delivery device containing oseltamivir and an H1 antagonist'
[patent_app_type] => B2
[patent_app_number] => 09/907486
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10139
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605302.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907486
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907486 | Drug delivery device containing oseltamivir and an H1 antagonist | Jul 16, 2001 | Issued |
| 09/856585 | CAPSULES CONTAINING ONE OR MORE ANTIGENIC SUBSTANCES FOR PREVENTION AND / OR TREATMENT OF AUTO - IMMUNE DISEASES | Jul 16, 2001 | Abandoned |
Array
(
[id] => 1502459
[patent_doc_number] => 06465010
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Means for creating a mass having structural integrity'
[patent_app_type] => B1
[patent_app_number] => 09/902751
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7301
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465010.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902751 | Means for creating a mass having structural integrity | Jul 11, 2001 | Issued |
Array
(
[id] => 1362360
[patent_doc_number] => 06565880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-20
[patent_title] => 'Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea'
[patent_app_type] => B2
[patent_app_number] => 09/902822
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5480
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/565/06565880.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902822 | Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea | Jul 10, 2001 | Issued |
Array
(
[id] => 6274905
[patent_doc_number] => 20020106412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Method and materials for controlling migration of binder liquid in a powder'
[patent_app_type] => new
[patent_app_number] => 09/904190
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9550
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106412.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904190
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904190 | Method and materials for controlling migration of binder liquid in a powder | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6079958
[patent_doc_number] => 20020081333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Orally administrable opioid formulations having extended duration of effect'
[patent_app_type] => new
[patent_app_number] => 09/891882
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9354
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09891882
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/891882 | Orally administrable opioid formulations having extended duration of effect | Jun 25, 2001 | Issued |
Array
(
[id] => 1513883
[patent_doc_number] => 06419958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-07-16
[patent_title] => 'Extended release formulation of venlafaxine hydrochloride'
[patent_app_type] => B2
[patent_app_number] => 09/884412
[patent_app_country] => US
[patent_app_date] => 2001-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4925
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/419/06419958.pdf
[firstpage_image] =>[orig_patent_app_number] => 09884412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/884412 | Extended release formulation of venlafaxine hydrochloride | Jun 18, 2001 | Issued |
Array
(
[id] => 1195899
[patent_doc_number] => 06726929
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Pharmaceutical mixture comprising a profen'
[patent_app_type] => B1
[patent_app_number] => 09/868092
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4287
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/726/06726929.pdf
[firstpage_image] =>[orig_patent_app_number] => 09868092
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/868092 | Pharmaceutical mixture comprising a profen | Jun 13, 2001 | Issued |
Array
(
[id] => 1406922
[patent_doc_number] => 06524618
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Directly compressible extended-release matrix formulation for metformin hydrochloride'
[patent_app_type] => B1
[patent_app_number] => 09/879748
[patent_app_country] => US
[patent_app_date] => 2001-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3907
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 458
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524618.pdf
[firstpage_image] =>[orig_patent_app_number] => 09879748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/879748 | Directly compressible extended-release matrix formulation for metformin hydrochloride | Jun 11, 2001 | Issued |
Array
(
[id] => 7078187
[patent_doc_number] => 20010041165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Effervescent bisphosphonate formulation'
[patent_app_type] => new
[patent_app_number] => 09/878557
[patent_app_country] => US
[patent_app_date] => 2001-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2272
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041165.pdf
[firstpage_image] =>[orig_patent_app_number] => 09878557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/878557 | Effervescent bisphosphonate formulation | Jun 10, 2001 | Abandoned |
Array
(
[id] => 1154443
[patent_doc_number] => 06761903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-13
[patent_title] => 'Clear oil-containing pharmaceutical compositions containing a therapeutic agent'
[patent_app_type] => B2
[patent_app_number] => 09/877541
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25354
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/761/06761903.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877541
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877541 | Clear oil-containing pharmaceutical compositions containing a therapeutic agent | Jun 7, 2001 | Issued |
Array
(
[id] => 1068423
[patent_doc_number] => 06843983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-18
[patent_title] => 'Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae'
[patent_app_type] => utility
[patent_app_number] => 09/875198
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2159
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/843/06843983.pdf
[firstpage_image] =>[orig_patent_app_number] => 09875198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/875198 | Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae | Jun 6, 2001 | Issued |
Array
(
[id] => 1308318
[patent_doc_number] => 06613358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-02
[patent_title] => 'Sustained-release composition including amorphous polymer'
[patent_app_type] => B2
[patent_app_number] => 09/877330
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 42
[patent_no_of_words] => 22843
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613358.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877330
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877330 | Sustained-release composition including amorphous polymer | Jun 6, 2001 | Issued |